Elsevier

Journal of Infection

Volume 40, Issue 2, March 2000, Pages 176-183
Journal of Infection

Regular Article
Prevalence of Hepatitis C Virus Infection Among Injecting Drug Users in Glasgow 1990–1996: are Current Harm Reduction Strategies Working?

https://doi.org/10.1053/jinf.2000.0647Get rights and content

Abstract

Objectives: To determine the prevalence of HCV antibodies among injecting drug users and to gauge the effectiveness of needle/syringe exchange in preventing the transmission of HCV infection.

Methods: Between 1990–1994 and in 1996, annual cross-sectional surveys of injecting drug users in Glasgow were conducted. In order to ensure as representative a sample as possible, the 1949 respondents were recruited from both ‘in-treatment’ and ‘out-of treatment’ settings. Injectors were interviewed about their risk behaviours for blood-borne viruses and provided a saliva sample which was initially tested, anonymously, for HIV antibodies, and subsequently tested for hepatitis C infection.

Results: Among 1949 injectors, the prevalence of salivary antibodies, indicative of hepatitis C viraemia, was 61% (95% confidence interval (CI) 59%–63%): the estimated prevalence of serum antibody positivity was 72%. Length of injecting, year of commencing drug injecting and the number of times in prison were predictive of antibody positivity. Thirty-one per cent of injectors who commenced their injecting after 1992, following the full establishment of needle/syringe exchange in the city, were salivary antibody positive, and the majority of their infections were acquired outside the prison setting. Respondents who began injecting after the introduction of needle/syringe exchange in the city were significantly less likely to test HCV antibody positive than those who commenced injecting prior to the advent of needle/syringe exchange, after adjusting for length of injecting career.

Conclusion: The prevalence of HCV among injectors in Glasgow has decreased during the era of needle/syringe exchange. However, there is evidence to suggest that the incidence of infection remains high. Since the prevalence of hepatitis C viraemia among the city's injecting population is extremely high, ongoing transmission is inevitable unless more effective interventions are identified and implemented urgently.

References (40)

  • JPH Lam et al.

    Infrequent vertical transmission of hepatitis C virus

    J Infect Dis

    (1993)
  • L Gruer et al.

    Building a city wide service for exchanging needles and syringes

    BMJ

    (1993)
  • M Frischer et al.

    Estimating population prevalence of injected drug use and HIV infection among injecting drug users in Glasgow

    Am J Epidemiol

    (1993)
  • M Frischer et al.

    Reduction in needle sharing among community wide sample of injecting drug users

    Int J STD and AIDS

    (1992)
  • D Goldberg et al.

    Monitoring the spread of HIV and AIDS in Scotland 1983–1994

    Scottish Med J

    (1996)
  • GE Bath et al.

    HIV prevalence in injecting drug users in Edinburgh. Fewer drug users share needles

    BMJ

    (1993)
  • A Taylor et al.

    Low and stable prevalence of HIV among Glasgow drug injectors

    Int J STD and AIDS

    (1994)
  • RP Brettle

    HIV and harm reduction for injection drug users

    AIDS

    (1991)
  • Bulletin on Narcotics

    (1993)
  • S Haw et al.

    The importance of multi-site sampling in determining the prevalence of HIV among drug injectors in Glasgow and London

    AIDS

    (1992)
  • Cited by (0)

    View full text